OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer’s Disease in Rats
Maaly A. Abd Elmaaboud, Remon S. Estfanous, Aliaa Atef, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1370-1370
Open Access | Times Cited: 13
Maaly A. Abd Elmaaboud, Remon S. Estfanous, Aliaa Atef, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1370-1370
Open Access | Times Cited: 13
Showing 13 citing articles:
Depolymerized peanut skin-derived proanthocyanidins alleviate cognitive dysfunction by inhibiting Aβ42 aggregation in Alzheimer’s disease
He Liu, Ziyan Zhang, Xiaoqing Li, et al.
Food Research International (2025), pp. 115747-115747
Closed Access | Times Cited: 1
He Liu, Ziyan Zhang, Xiaoqing Li, et al.
Food Research International (2025), pp. 115747-115747
Closed Access | Times Cited: 1
Targeting Autophagy, Apoptosis, and Oxidative Perturbations with Dapagliflozin Mitigates Cadmium-Induced Cognitive Dysfunction in Rats
Hany H. Arab, Ahmed H. Eid, Shuruq E. Alsufyani, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3000-3000
Open Access | Times Cited: 13
Hany H. Arab, Ahmed H. Eid, Shuruq E. Alsufyani, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3000-3000
Open Access | Times Cited: 13
The Therapeutic Potential of Four Main Compounds of Zanthoxylum nitidum (Roxb.) DC: A Comprehensive Study on Biological Processes, Anti-Inflammatory Effects, and Myocardial Toxicity
Xiaohan Li, Qi Wang, Ling Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 524-524
Open Access | Times Cited: 4
Xiaohan Li, Qi Wang, Ling Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 524-524
Open Access | Times Cited: 4
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Reducing Alzheimer’s Disease Risk with SGLT2 Inhibitors: From Glycemic Control to Neuroprotection
Mehdi Alami, Mojgan Morvaridzadeh, Abdellatif El Khayari, et al.
Ageing Research Reviews (2025), pp. 102751-102751
Closed Access
Mehdi Alami, Mojgan Morvaridzadeh, Abdellatif El Khayari, et al.
Ageing Research Reviews (2025), pp. 102751-102751
Closed Access
Rodent Models for Alzheimer Disease: Experimental Induction, Pathophysiological Mechanisms, and Biomarker Profiling
Riddhi Rane, Bhagya V Rao, Joshnavi Tadimari
(2025), pp. 1968-1991
Closed Access
Riddhi Rane, Bhagya V Rao, Joshnavi Tadimari
(2025), pp. 1968-1991
Closed Access
Dapagliflozin alleviates arsenic trioxide-induced hepatic injury in rats via modulating PI3K/AkT/mTOR, STAT3/SOCS3/p53/MDM2 signaling pathways and miRNA-21, miRNA-122 expression
Basel A. Abdel‐Wahab, Ehab A. M. El‐Shoura, Mohammed Shafiuddin Habeeb, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111325-111325
Closed Access | Times Cited: 10
Basel A. Abdel‐Wahab, Ehab A. M. El‐Shoura, Mohammed Shafiuddin Habeeb, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111325-111325
Closed Access | Times Cited: 10
The role and mechanism of dapagliflozin in Alzheimer disease: A review
Ping Chen, Lihui Liang, Yuhan Dai, et al.
Medicine (2024) Vol. 103, Iss. 39, pp. e39687-e39687
Open Access | Times Cited: 1
Ping Chen, Lihui Liang, Yuhan Dai, et al.
Medicine (2024) Vol. 103, Iss. 39, pp. e39687-e39687
Open Access | Times Cited: 1
Exploring role of citrus fruits in comorbid neurodegenerative disorders associated with psoriasis
Asgar Ali, Ankit Chaudhary, Alok Nath Sharma, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
Asgar Ali, Ankit Chaudhary, Alok Nath Sharma, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
Repurposing Dapagliflozin for Mitigation of the Kidney Injury Triggered by Cadmium in Rats: Role of Autophagy, Apoptosis, and the SIRT1/Nrf2/HO-1 Pathway
Hany H. Arab, Musaad M Althobaiti, Abdulaziz Alharthi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1690-1690
Open Access | Times Cited: 1
Hany H. Arab, Musaad M Althobaiti, Abdulaziz Alharthi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1690-1690
Open Access | Times Cited: 1
A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer’s Disease
Qiuchen Wang, Mengjie Fu, Lihui Gao, et al.
Journal of Alzheimer s Disease (2024), pp. 1-12
Closed Access
Qiuchen Wang, Mengjie Fu, Lihui Gao, et al.
Journal of Alzheimer s Disease (2024), pp. 1-12
Closed Access
Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer’s Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling
Hemat A. Elariny, Ahmed M. Kabel, Heba Mohammed Refat M. Selim, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1805-1805
Open Access
Hemat A. Elariny, Ahmed M. Kabel, Heba Mohammed Refat M. Selim, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1805-1805
Open Access
Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases
Vishal Kumar, Puneet Kumar
Inflammopharmacology (2024)
Closed Access
Vishal Kumar, Puneet Kumar
Inflammopharmacology (2024)
Closed Access
Repurposing dapagliflozin for Alzheimer's disease: a mechanistic exploration
Marwa M. Saeed
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access
Marwa M. Saeed
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access
